Method of treating brain cancer

Details for Australian Patent Application No. 2008236993 (hide)

Owner Myriad Pharmaceuticals, Inc.

Inventors Laughlin, Mark

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008236993

PCT Pub. Number WO2008/124822

Priority 60/910,975 10.04.07 US

Filing date 10 April 2008

Wipo publication date 16 October 2008

International Classifications

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/124822 Priority application(s): WO2008/124822

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008236994-Method of treating melanoma

2008236987-Cushioning system for pneumatic cylinder of differential engine